CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,212,947 | +24.9% | 44,520 | +2.0% | 0.01% | +33.3% |
| Q2 2023 | $971,324 | -6.1% | 43,655 | -8.6% | 0.01% | -14.3% |
| Q1 2023 | $1,034,460 | +7.0% | 47,759 | +0.3% | 0.01% | 0.0% |
| Q4 2022 | $967,122 | -20.5% | 47,618 | +0.4% | 0.01% | -22.2% |
| Q3 2022 | $1,216,000 | +8.9% | 47,441 | +1.0% | 0.01% | +12.5% |
| Q2 2022 | $1,117,000 | -2.1% | 46,963 | -7.3% | 0.01% | +33.3% |
| Q1 2022 | $1,141,000 | -0.9% | 50,684 | -12.8% | 0.01% | 0.0% |
| Q4 2021 | $1,151,000 | -4.6% | 58,131 | -5.2% | 0.01% | 0.0% |
| Q3 2021 | $1,206,000 | -13.7% | 61,291 | -3.5% | 0.01% | +20.0% |
| Q2 2021 | $1,397,000 | -10.3% | 63,518 | -3.0% | 0.01% | 0.0% |
| Q1 2021 | $1,558,000 | -10.0% | 65,489 | -1.1% | 0.01% | -16.7% |
| Q4 2020 | $1,732,000 | +48.5% | 66,203 | -1.2% | 0.01% | 0.0% |
| Q3 2020 | $1,166,000 | +1.0% | 67,006 | -2.3% | 0.01% | 0.0% |
| Q2 2020 | $1,154,000 | +45.9% | 68,581 | +3.1% | 0.01% | +50.0% |
| Q1 2020 | $791,000 | -6.4% | 66,534 | -4.7% | 0.00% | +33.3% |
| Q4 2019 | $845,000 | -16.7% | 69,809 | -2.6% | 0.00% | -25.0% |
| Q3 2019 | $1,014,000 | +24.0% | 71,708 | -2.3% | 0.00% | +33.3% |
| Q2 2019 | $818,000 | -6.6% | 73,407 | -1.6% | 0.00% | 0.0% |
| Q1 2019 | $876,000 | -14.5% | 74,593 | -2.7% | 0.00% | -25.0% |
| Q4 2018 | $1,024,000 | -6.0% | 76,680 | -1.3% | 0.00% | 0.0% |
| Q3 2018 | $1,089,000 | -7.6% | 77,671 | +3.5% | 0.00% | 0.0% |
| Q2 2018 | $1,179,000 | +23.1% | 75,015 | +28.7% | 0.00% | +33.3% |
| Q1 2018 | $958,000 | -27.3% | 58,267 | -20.1% | 0.00% | -25.0% |
| Q4 2017 | $1,317,000 | +11.7% | 72,902 | +19.3% | 0.00% | 0.0% |
| Q3 2017 | $1,179,000 | +76.8% | 61,110 | +8.1% | 0.00% | +100.0% |
| Q2 2017 | $667,000 | +32.3% | 56,541 | +22.9% | 0.00% | 0.0% |
| Q1 2017 | $504,000 | +61.5% | 46,000 | +7.1% | 0.00% | +100.0% |
| Q4 2016 | $312,000 | -99.9% | 42,958 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $279,949,000 | +19.2% | 43,069 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $234,796,000 | +38.1% | 43,003 | +18.6% | 0.00% | 0.0% |
| Q1 2016 | $170,000,000 | -6.1% | 36,250 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $181,000,000 | +132016.8% | 36,250 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $137,000 | -99.9% | 36,313 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $217,983,000 | +16.0% | 36,270 | +8.1% | 0.00% | 0.0% |
| Q1 2015 | $187,863,000 | +86.7% | 33,547 | 0.0% | 0.00% | – |
| Q4 2014 | $100,641,000 | +7.7% | 33,547 | -3.8% | 0.00% | – |
| Q3 2014 | $93,465,000 | -4.4% | 34,875 | -0.1% | 0.00% | – |
| Q2 2014 | $97,723,000 | -38.1% | 34,901 | -3.6% | 0.00% | -100.0% |
| Q1 2014 | $157,801,000 | +38.7% | 36,193 | +2.5% | 0.00% | 0.0% |
| Q4 2013 | $113,743,000 | +100.5% | 35,324 | -1.0% | 0.00% | – |
| Q3 2013 | $56,728,000 | -3.3% | 35,678 | +5.2% | 0.00% | – |
| Q2 2013 | $58,663,000 | – | 33,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |